https://www.marketscreener.com/quote/stock/ASTELLAS-PHARMA-INC-6491262/news/Astellas-Pharma-Groundbreaking-EV-302-Trial-Significantly-Extends-Overall-Survival-and-Progression-45125071/?utm_source=telegram&utm_medium=social&utm_campaign=share